XML 69 R57.htm IDEA: XBRL DOCUMENT v3.25.1
Capitalized Software Development Costs, Work in Progress - Schedule of Continues to Assess the Carrying Amount of Capitalized Software for Impairment (Details) - USD ($)
 8 Months Ended 12 Months Ended
Aug. 20, 2024
Dec. 31, 2023
Dec. 31, 2024
Schedule of Continues to Assess the Carrying Amount of Capitalized Software for Impairment [Line Items]      
Gross carrying amount   $ 589,645 $ 839,085
Additions $ 150,372 249,440 516,544
Impaired [1]     (202,968)
Reclassified to Intangibles & Expenses [2]     (1,046,761)
Net carrying value   839,085 105,900
Capitalized Software Development costs, work in progress [Member]      
Schedule of Continues to Assess the Carrying Amount of Capitalized Software for Impairment [Line Items]      
Gross carrying amount   589,645 839,085
Additions   249,440 516,544
Impaired [1]     (202,968)
Reclassified to Intangibles & Expenses [2]     (1,046,761)
Net carrying value   $ 839,085 $ 105,900
[1] During year-end 2024, the Company performed an assessment of capitalized software for impairment. As a result, the Company impaired Work-in-Progress (“WIP”) related to reAlpha HUMINT and our technology for completing Syndications due to no further development and lack of use cases. The impaired amount was removed from the carrying value of WIP and recorded as an impairment expense in the financial statements.
[2] On August 20, 2024, the Company reclassified a portion of WIP to intangible assets, specifically: $156,800 to GENA, $593,843 to the reAlpha platform and also reclassified the additions made to Claire post reclassification of $150,372. Both Claire and GENA began amortization over five years starting August 20, 2024, in accordance with ASC 350 and also includes reclassification of capitalized cost of $145,746 to expenses during the period ended December 31, 2024.